The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeBlend
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 131.35 | 1.59 | +1.23% |
Franklin Biotechnology Discovery A | |||
STCZX | 17.64 | -0.04 | -0.23% |
Virtus Silvant Large-Cap Growth Stk R6 | |||
CLREX | 55.54 | -0.16 | -0.29% |
Columbia Balanced Inst2 | |||
PSLIX | 30.41 | -0.13 | -0.43% |
Principal SmallCap Inst | |||
GCSVX | 9.75 | -0.06 | -0.61% |
Geneva SMID Cap Growth Institutional |
A.I.dvisor indicates that over the last year, CHRSX has been closely correlated with VSMPX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHRSX jumps, then VSMPX could also see price increases.
Ticker / NAME | Correlation To CHRSX | 1D Price Change % | ||
---|---|---|---|---|
CHRSX | 100% | -0.18% | ||
VSMPX - CHRSX | 92% Closely correlated | -0.26% | ||
VSTSX - CHRSX | 92% Closely correlated | -0.27% | ||
VITSX - CHRSX | 92% Closely correlated | -0.27% | ||
VTSMX - CHRSX | 92% Closely correlated | -0.27% | ||
VTSAX - CHRSX | 92% Closely correlated | -0.27% | ||
More |